2,627
Views
4
CrossRef citations to date
0
Altmetric
Hematology

Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose

ORCID Icon, , ORCID Icon, ORCID Icon, &
Pages 561-570 | Received 16 Mar 2022, Accepted 08 Apr 2022, Published online: 04 May 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Shanlian Hu, Depei Wu, Jing Wu, Yabing Zhang, Mette Bøgelund, Johannes Pöhlmann & Richard F Pollock. (2023) Disutilities Associated with Intravenous Iron Infusions: Results from a Time Trade-off Survey and Diminishing Marginal Utility Model for Treatment Attributes in China. Patient Related Outcome Measures 14, pages 253-267.
Read now
Tariq H Iqbal, Nicholas Kennedy, Anjan Dhar, Waqas Ahmed & Richard F. Pollock. Cost-utility analysis of ferric derisomaltose versus ferric carboxymaltose in patients with inflammatory bowel disease and iron deficiency anemia in England. Journal of Medical Economics 0:0, pages 1-19.
Read now

Articles from other publishers (2)

Lu Yun, Zhu YuMei, Vallish BN, Qingu Tang & Chang Feng. (2023) The Efficacy, Safety, and Economic Outcomes of Using Ferric Derisomaltose for the Management of Iron Deficiency in China: A Rapid Health Technology Assessment. Cureus.
Crossref
L. D. Belotserkovtseva, L. V. Kovalenko, V. N. Zinin, S. E. Ivannikov & M. R. Keldasova. (2023) Iron deficiency anemia in pregnant women. Ural Medical Journal 22:5, pages 140-149.
Crossref